Hongjian Pu

Dr. Hongjian Pu

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
WCWei Cai
Wei Cai
Ligen ShiLigen Shi
Ligen Shi
JZJingyan Zhao
Jingyan Zhao
FXFei Xu
Fei Xu
CDConnor Dufort
Connor Dufort
JCJun Chen
Jun Chen
Immunomodulation holds therapeutic promise against brain injuries, but leveraging this approach requires a precise understanding of mechanisms. We report that CD8+CD122+CD49dlo T regulatory-like cells (CD8+ TRLs) are among the earliest lymphocytes to infiltrate mouse brains after ischemic stroke and temper inflammation; they also confer neuroprotection. TRL depletion worsened stroke outcomes, an effect reversed by CD8+ TRL reconstitution. The CXCR3/CXCL10 axis served as the brain-homing mechanism for CD8+ TRLs. Upon brain entry, CD8+ TRLs were reprogrammed to upregulate leukemia inhibitory factor (LIF) receptor, epidermal growth factor–like transforming growth factor (ETGF), and interleukin 10 (IL-10). LIF/LIF receptor interactions induced ETGF and IL-10 production in CD8+ TRLs. While IL-10 induction was important for the antiinflammatory effects of CD8+ TRLs, ETGF provided direct neuroprotection. Poststroke intravenous transfer of CD8+ TRLs reduced infarction, promoting long-term neurological recovery in young males or aged mice of both sexes. Thus, these unique CD8+ TRLs serve as early responders to rally defenses against stroke, offering fresh perspectives for clinical translation.

1 December 2017 in Neurochemistry International
Verified
Journal Article
Closed access
JZJun Zhang
Jun Zhang
HPHongjian Pu
Hongjian Pu
HZHaiyue Zhang
Haiyue Zhang
ZWZhishuo Wei
Zhishuo Wei
XJXiaoyan Jiang
Xiaoyan Jiang
LCLing Chen
Ling Chen

5 August 2020 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
PDF file
HPHongjian Pu
Hongjian Pu
XZXuan Zheng
Xuan Zheng
XJXiaoyan Jiang
Xiaoyan Jiang
HMHongfeng Mu
Hongfeng Mu
FXFei Xu
Fei Xu
JCJun Chen
Jun Chen
Long-term neurological recovery after severe traumatic brain injury (TBI) is strongly linked to the repair and functional restoration of injured white matter. Emerging evidence suggests that the anti-inflammatory cytokine interleukin-4 (IL-4) plays an important role in promoting white matter integrity after cerebral ischemic injury. Here, we report that delayed intranasal delivery of nanoparticle-packed IL-4 boosted sensorimotor neurological recovery in a murine model of controlled cortical impact, as assessed by a battery of neurobehavioral tests for up to five weeks. Post-injury IL-4 treatment failed to reduce macroscopic brain lesions after TBI, but preserved the structural and functional integrity of white matter, at least in part through oligodendrogenesis. IL-4 directly facilitated the differentiation of oligodendrocyte progenitor cells (OPCs) into mature myelin-producing oligodendrocytes in primary cultures, an effect that was attenuated by selective PPARγ inhibition. IL-4 treatment after TBI in vivo also failed to stimulate oligodendrogenesis or improve white matter integrity in OPC-specific PPARγ conditional knockout (cKO) mice. Accordingly, IL-4-afforded improvements in sensorimotor neurological recovery after TBI were markedly impaired in the PPARγ cKO mice compared to wildtype controls. These results support IL-4 as a potential novel neurorestorative therapy to improve white matter functionality and mitigate the long-term neurological consequences of TBI.

17 April 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
HPHongjian Pu
Hongjian Pu
YSYejie Shi
Yejie Shi
LZLili Zhang
Lili Zhang
ZLZhengyu Lu
Zhengyu Lu
QYQing Ye
Qing Ye
JCJun Chen
Jun Chen
Significance: Therapies that boost brain plasticity and repair processes without deleterious side effects have the potential to transform the clinical management of stroke. Here we report that tissue plasminogen activator (tPA), known as a clot buster for clinical treatment of ischemic stroke, exerts additional neurorestorative effects in a murine model of stroke by stimulating axonal regeneration and facilitating functional recovery. Importantly, functional restoration was independent of tPA’s proteolytic activity—a mutant, protease-inactive form of tPA, tPA-S478A, was as effective as regular tPA. Results of our preclinical studies support the view that tPA-S478A has the therapeutic potential to enhance brain regeneration and functional restoration in stroke victims. Unlike regular tPA, tPA-S478A does not bear the risk of inducing intracerebral hemorrhage.

14 July 2021 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
PDF file
HPHongjian Pu
Hongjian Pu
CMCheng Ma
Cheng Ma
YZYongfang Zhao
Yongfang Zhao
YWYangfan Wang
Yangfan Wang
WZWenting Zhang
Wenting Zhang
JCJun Chen
Jun Chen
Traumatic brain injury (TBI) is commonly followed by long-term cognitive deficits that severely impact the quality of life in survivors. Recent studies suggest that microglial/macrophage (Mi/MΦ) polarization could have multidimensional impacts on post-TBI neurological outcomes. Here, we report that repetitive intranasal delivery of interleukin-4 (IL-4) nanoparticles for 4 weeks after controlled cortical impact improved hippocampus-dependent spatial and non-spatial cognitive functions in adult C57BL6 mice, as assessed by a battery of neurobehavioral tests for up to 5 weeks after TBI. IL-4-elicited enhancement of cognitive functions was associated with improvements in the integrity of the hippocampus at the functional (e.g., long-term potentiation) and structural levels (CA3 neuronal loss, diffusion tensor imaging of white matter tracts, etc.). Mechanistically, IL-4 increased the expression of PPARγ and arginase-1 within Mi/MΦ, thereby driving microglia toward a global inflammation-resolving phenotype. Notably, IL-4 failed to shift microglial phenotype after TBI in Mi/MΦ-specific PPARγ knockout (mKO) mice, indicating an obligatory role for PPARγ in IL-4-induced Mi/MΦ polarization. Accordingly, post-TBI treatment with IL-4 failed to improve hippocampal integrity or cognitive functions in PPARγ mKO mice. These results demonstrate that administration of exogenous IL-4 nanoparticles stimulates PPARγ-dependent beneficial Mi/MΦ responses, and improves hippocampal function after TBI.

1 June 2019 in Neurobiology of Disease
Verified
Journal Article
Closed access
XJXiaoyan Jiang
Xiaoyan Jiang
JSJun Suenaga
Jun Suenaga
HPHongjian Pu
Hongjian Pu
ZWZhishuo Wei
Zhishuo Wei
ASAmanda D. Smith
Amanda D. Smith
JCJun Chen
Jun Chen